Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 4;14(2):e241105.
doi: 10.1136/bcr-2020-241105.

Steroid harms if given early in COVID-19 viraemia

Kanupriya Arora  1 , Prasan Kumar Panda  2
Affiliations
Case Reports

Steroid harms if given early in COVID-19 viraemia

Kanupriya Arora et al. BMJ Case Rep. .

Abstract

COVID-19 is a biphasic illness with an initial viraemia phase and later effective adaptive immune phase, except in a minority of people who develop severe disease. Immune regulation is the key target to treat COVID illness. In anticipation, an elderly man self-medicated himself with dexamethasone on the day of symptom onset of a flu-like illness, took other symptomatic measures and was tested positive for SARS-CoV-2. His condition deteriorated with each passing day resulting in hospitalisation. He demanded oxygen and declared as severe COVID. With supportive treatment, he recovered after the 20th day of illness. Immunosuppression and anti-inflammation are likely to benefit when the immune response is dysregulated and turning into a cytokine storm. A medication that has saved many could be the one predisposing to severity if taken as a preventive measure, too early in the disease course, especially the viraemia phase.

Keywords: COVID-19; general practice / family medicine; global health; infectious diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. RECOVERY Collaborative Group, Horby P, Lim WS, et al. . Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020. 10.1056/NEJMoa2021436. [Epub ahead of print: 17 Jul 2020]. - DOI - PMC - PubMed
    1. Veronese N, Demurtas J, Yang L, et al. . Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature. Front Med 2020;7:170. 10.3389/fmed.2020.00170 - DOI - PMC - PubMed
    1. García LF, Luis F. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol 2020;11:1441. 10.3389/fimmu.2020.01441 - DOI - PMC - PubMed
    1. Sharma R, Agarwal M, Gupta M. Clinical characteristics and differential clinical diagnosis of novel coronavirus disease 2019 (COVID-19). Coronavirus Disease 2019 (COVID-19) 2020:55–70. 10.1007/978-981-15-4814-7_6 - DOI
    1. García LF, Response I. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol 2020;11:1441. 10.3389/fimmu.2020.01441 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources